KMR Group is a leader in the area of biopharmaceutical benchmarking in R&D. We offer peerless data on topics ranging from clinical productivity to R&D metrics including cycle times, attrition, project costs, enrollment cycle times, site metrics and more. KMR works closely with participants to shape the content of the study and to answer questions of most interest. Our studies are conducted with the utmost integrity, emphasizing data quality and value added analysis with a firm commitment to confidentiality. For more information on one of the following programs, or any complement application, click on the link or contact KMR.
Pharmaceutical Benchmarking Forum (PBF) studies
The following studies are conducted on behalf of the Pharmaceutical Benchmarking Forum. For more information about the PBF or any of its studies, contact KMR.
- R&D General Metrics
- Drug Discovery
- Biologics R&D
- Project Cost
- Clinical Development Studies
For more information about KMR’s Clinical Development program or any of the associated applications, contact KMR.
- Enrollment Productivity Study
- Clinical Trial Cycle Time
- Clinical Development Productivity
- Clinical Development Sourcing
